McCarthy Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

McCarthy Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	-$2K	–	154
2022 Q1	$2K	Hold	150	–	–	﹤0.01%	285
2021 Q4	$2K	Hold	150	–	–	﹤0.01%	284
2021 Q3	$2K	Hold	150	–	–	﹤0.01%	282
2021 Q2	$2K	Hold	150	–	–	﹤0.01%	337
2021 Q1	$2K	Hold	150	–	–	﹤0.01%	299
2020 Q4	$2K	Buy	+150	New	+$1.64K	﹤0.01%	277

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

McCarthy Asset Management's IRWD Position: Q2 2022 in Review

McCarthy Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 150 shares — an estimated $2K sold.

McCarthy Asset Management first reported a position in IRWD in Q4 2020 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

McCarthy Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 150 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $2K.
McCarthy Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's Ironwood Pharmaceuticals position peaked at $2K in Q1 2022.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.